Keywords
Last Name
Institution

CRAIG F TELLER

TitleClinical Instructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Dermatology
DivisionDermatology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bruce S, Roberts W, Teller C, Colvan L. The Effects of a Daily Skincare Regimen on Maintaining the Benefits Obtained from Previous Chemical Resurfacing Treatments. J Drugs Dermatol. 2016 Sep 1; 15(9):1145-50. PMID: 27602981.
      View in: PubMed
    2. Narurkar VA, Cohen JL, Dayan S, Kaminer MS, Rivkin A, Shamban A, Sykes JM, Teller CF, Weinkle SH, Werschler WP, Drinkwater A, Pucci ML, Gallagher CJ. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study. Dermatol Surg. 2016 May; 42 Suppl 2:S177-91. PMID: 27128246.
      View in: PubMed
    3. Kimball AB, Rothman KJ, Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM. OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results. J Am Acad Dermatol. 2015 Jan; 72(1):115-22. PMID: 25264239; PMCID: PMC4758511.
    4. Vleggaar D, Fitzgerald R, Lorenc ZP, Andrews JT, Butterwick K, Comstock J, Hanke CW, O'Daniel TG, Palm MD, Roberts WE, Sadick N, Teller CF. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J Drugs Dermatol. 2014 Apr; 13(4 Suppl):s44-51. PMID: 24719078.
      View in: PubMed
    5. Strober BE, Poulin Y, Teller C, Wang Y, Williams DA, Goldblum OM. Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy. J Eur Acad Dermatol Venereol. 2014 Dec; 28(12):1701-6. PMID: 24422992.
      View in: PubMed
    6. Kimball AB, Pariser D, Yamauchi PS, Menter A, Teller CF, Shi Y, Yong M, Creamer K, Hooper M, Aras G, Kricorian G, Gelfand JM. OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis. J Am Acad Dermatol. 2013 May; 68(5):756-64. PMID: 23357569.
      View in: PubMed
    7. Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol. 2008 Aug; 159(2):322-30. PMID: 18503600.
      View in: PubMed
    8. Cohen PR, Schulze KE, Teller CF, Nelson BR. Intralesional methotrexate for keratoacanthoma of the nose. Skinmed. 2005 Nov-Dec; 4(6):393-5. PMID: 16276163.
      View in: PubMed
    9. Bogle MA, Teller CF, Tschen JA, Smith CA, Wang A. Primary hyperoxaluria in a 27-year-old woman. J Am Acad Dermatol. 2003 Oct; 49(4):725-8. PMID: 14512927.
      View in: PubMed
    10. Chen TM, Crow MK, Teller C. Angiotropic large-cell lymphoma with striking blue plaques. J Am Acad Dermatol. 2003 Apr; 48(4):633-4. PMID: 12664037.
      View in: PubMed
    11. Pharis DB, Teller C, Wolf JE. Cutaneous manifestations of sports participation. J Am Acad Dermatol. 1997 Mar; 36(3 Pt 1):448-59. PMID: 9091479.
      View in: PubMed
    TELLER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _